Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D
Go back to Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D| (NASDAQ: WGRX) | Delayed: 3.48 -0.24 (6.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.72 | 52 Week High | $ | |||
| Open | $3.62 | 52 Week Low | $ | |||
| Day High | $3.79 | P/E | N/A | |||
| Day Low | $3.40 | EPS | $ | |||
| Volume | 31,673 | |||||
